Kamsing Healthcare (SGX:BAC) Q2 FY2025 results
Key Financial Results
Revenue: S$1.56 million (up 13% from 2Q24).
Net profit: S$257.0k (up from a S$576.0k loss in 2Q24).
Profit margin: 17% (up from net loss in 2Q24). Profitability improvement primarily driven by reduced expenses.
All figures shown in the chart above are for the trailing twelve month (TTM) period.
Kamsing Healthcare’s shares are little changed from a week ago.
Risk Analysis
However, it’s worth noting that we’ve found 7 warning signs for Camsing Healthcare (5 shouldn’t be ignored!) that you should take into consideration.
Have feedback about this article? Concerns about the content? Stay in touch Contact us directly or email us at editorial-team (at) simplywallst.com.
This article by Simply Wall St is of general nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodology, and our articles are not intended as financial advice. It is not a recommendation to buy or sell stocks, and does not take into account your objectives or financial situation. We aim to provide long-term analysis driven by fundamental data. Please note that our analysis may not take into account the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any of the stocks mentioned herein.
